These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6871812)

  • 1. The Eastern Ontario survey: a study of drug-treated psychiatric problems in the mentally handicapped.
    Tu JB; Smith JT
    Can J Psychiatry; 1983 Jun; 28(4):270-6. PubMed ID: 6871812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatric and behavioural disorders amongst older severely mentally handicapped inpatients.
    James DH
    J Ment Defic Res; 1986 Dec; 30 ( Pt 4)():341-5. PubMed ID: 3806661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Droperidol in the management of hyperactivity, self-mutilation and aggression in mentally handicapped patients.
    Burns ME
    J Int Med Res; 1980; 8(1):31-3. PubMed ID: 7358201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic management of aggressivity and self-mutilation in the mentally retarded.
    Lapierre YD; Reesal R
    Psychiatr Clin North Am; 1986 Dec; 9(4):745-54. PubMed ID: 3543893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proxy and self-reported Quality of Life in adults with intellectual disabilities: Impact of psychiatric symptoms, problem behaviour, psychotropic medication and unmet needs.
    Koch AD; Vogel A; Becker T; Salize HJ; Voss E; Werner A; Arnold K; Schützwohl M
    Res Dev Disabil; 2015; 45-46():136-46. PubMed ID: 26233765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric disturbance in mentally handicapped patients. A prospective study of current clinical usage of depot fluphenazine in hospitals for the mentally handicapped.
    Craft MJ; Schiff AA
    Br J Psychiatry; 1980 Sep; 137():250-5. PubMed ID: 7437659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy for mental health problems in people with intellectual disability.
    Ji NY; Findling RL
    Curr Opin Psychiatry; 2016 Mar; 29(2):103-25. PubMed ID: 26779860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Professionals' perceptions of psychotropic medication in residential facilities for individuals with mental retardation.
    Singh NN; Ellis CR; Donatelli LS; Williams DE; Ricketts RW; Goza AB; Perlman N; Everly DE; Best AM; Singh YN
    J Intellect Disabil Res; 1996 Feb; 40 ( Pt 1)():1-7. PubMed ID: 8930051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practitioner versus medication-expert opinion on psychiatric pharmacotherapy of mentally retarded patients with mental disorders.
    Patel NC; Crismon ML; Rush AJ; Frances A
    Am J Health Syst Pharm; 2001 Oct; 58(19):1824-9. PubMed ID: 11596698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenging behavior in adults with epilepsy and intellectual disability: An analysis of epilepsy characteristics.
    van Ool JS; Snoeijen-Schouwenaars FM; Tan IY; Jurgen Schelhaas H; Aldenkamp AP; Hendriksen JGM
    Epilepsy Behav; 2018 Sep; 86():72-78. PubMed ID: 30153936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotropic prescribing in people with intellectual disability and challenging behaviour.
    Sheehan R; Strydom A; Morant N; Pappa E; Hassiotis A
    BMJ; 2017 Aug; 358():j3896. PubMed ID: 28821479
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychopharmacotherapy in children and adults with intellectual disability.
    Santosh PJ; Baird G
    Lancet; 1999 Jul; 354(9174):233-42. PubMed ID: 10421318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological and psychiatric investigations into a group of mentally handicapped subjects with self-injurious behaviour.
    Matin MA; Rundle AT
    J Ment Defic Res; 1980 Jun; 24(2):77-85. PubMed ID: 7411598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychopharmacology research for individuals with mental retardation: methodological issues and suggestions.
    Matson JL; Bielecki J; Mayville SB; Matson ML
    Res Dev Disabil; 2003; 24(3):149-57. PubMed ID: 12742384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychopathology in institutionalised mentally retarded adults.
    Linaker OM; Nitter R
    Br J Psychiatry; 1990 Apr; 156():522-5. PubMed ID: 2386861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personality disorder in mental handicap.
    Reid AH; Ballinger BR
    Psychol Med; 1987 Nov; 17(4):983-7. PubMed ID: 3432470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with psychotropic medication in mental retardation facilities.
    Tu J; Smith JT
    Compr Psychiatry; 1979; 20(3):289-95. PubMed ID: 446009
    [No Abstract]   [Full Text] [Related]  

  • 18. A guide to psychopharmacological treatment of patients with intellectual disability in psychiatry.
    Molina-Ruiz RM; Martín-Carballeda J; Asensio-Moreno I; Montañés-Rada F
    Int J Psychiatry Med; 2017 Mar; 52(2):176-189. PubMed ID: 28792289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychopathology in people with epilepsy and intellectual disability; an investigation of potential explanatory variables.
    Espie CA; Watkins J; Curtice L; Espie A; Duncan R; Ryan JA; Brodie MJ; Mantala K; Sterrick M
    J Neurol Neurosurg Psychiatry; 2003 Nov; 74(11):1485-92. PubMed ID: 14617702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.